chloramphenicol has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Amphenicol: Chloramphenicol and its derivatives.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shwachman, H | 1 |
| Redmond, A | 1 |
| Khaw, KT | 1 |
| Hermier, M | 1 |
| Gilly, R | 1 |
| Chevallier, G | 1 |
2 other studies available for chloramphenicol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.
Topics: Anemia; Body Weight; Chloramphenicol; Chlortetracycline; Cough; Cystic Fibrosis; Diabetes Mellitus, | 1970 |
[The course of mucoviscidosis. Experience at Giens Center].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bronchoscopy; Chloramphenicol; Cystic Fibrosis; Diab | 1969 |